PMCID: PMC11817741
In this section we will review past and present GLP-1RA data, so that we are better able to come to a verdict on future trial readouts
Employer coalitions could pool risk, subscription models may spread costs more predictably, and outcomes-based contracts could tie payments to real-world health improvements
My advice to entrepreneurs is, like, You can just do things, he said
Collectively, the GLP-1-microbiota-metabolite-gut-brain-muscle network integrates metabolic, inflammatory, and neuroendocrine pathways to support skeletal muscle maintenance, enhance functional strength, and reduce sarcopenia risk, highlighting the potential of GLP-1-based and microbiota-targeted strategies in the management of aging-related and metabolic disorders